Comparative impact of antiviral therapies on postoperative recurrence risk in patients with hepatitis B virus-related hepatocellular carcinoma

doi:10.4251/wjgo.v17.i9.106297

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-1)

Sum=0

Sep 15, 2025 (publication date) through Sep 15, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Sep 15, 2025; 17(9): 106297
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.106297

Open in New Tab Full Size Figure Download Figure

Figure 1 The flow chart for this study. PSM: Propensity score matching; ETV: Entecavir; HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; TDF: Tenofovir disoproxil.

Open in New Tab Full Size Figure Download Figure

Figure 2 Cumulative incidence of recurrence after surgical resection of hepatocellular cancer. The cumulative incidence rates of hepatocellular cancer recurrence are presented. The Kaplan-Meier method and log-rank test were utilized to evaluate these rates. ETV: Entecavir; HCC: Hepatocellular carcinoma; TDF: Tenofovir disoproxil.

Citation: Liu HM, Zhang X, Huang HY, Sun JM, Tong QD. Comparative impact of antiviral therapies on postoperative recurrence risk in patients with hepatitis B virus-related hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(9): 106297
URL: https://www.wjgnet.com/1948-5204/full/v17/i9/106297.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.106297